dr. lopategui on the evolution of targeted therapies in nsclc
Published 4 years ago • 155 plays • Length 1:18Download video MP4
Download video MP3
Similar videos
-
0:52
dr. lopategui on the evolution of molecular testing in nsclc
-
2:12
dr. pennell on the evolution of targeted treatment in nsclc
-
4:23
evolution of targeted therapy in advanced nsclc
-
3:16
dr herbst on the evolution of targeted therapies for egfr nsclc
-
1:14
dr. lopategui on the use of liquid biopsies in lung cancer
-
1:44
dr. lopategui on the implications of genomic sequencing in lung cancer
-
2:22
dr. pennell on the evolution of targeting her2 in lung cancer
-
1:54
dr. langer discusses the impact of targeted therapy in nsclc
-
1:18
dr. natale on the evolution of immunotherapy in nsclc
-
4:05
the evolution of alk/ros1-targeted therapy in nsclc
-
4:55
evolution of therapy in lung cancer - 2022 program: targeted therapies forum
-
1:05
dr. aggarwal on emerging treatment approaches in alk nsclc
-
4:08
targeted therapies in lung cancer
-
3:30
the cost-effectiveness of targeted therapies in nsclc
-
0:58
dr. urbanic on the evolution of radiation in nsclc
-
4:02
treatment of egfr mutated nsclc - 2022 program: targeted therapies forum - english
-
4:59
challenges in targeted drug development and treatment in lung cancer
-
2:20
selecting patients with nsclc who benefit from immunotherapy or targeted therapies
-
1:31
dr. gold on the future of osimertinib in lung cancer